DAVITA INC. Marketable Securities
DAVITA INC. (DVA) had Marketable Securities of $58.28 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2026-08-04
- 2026-06-30: Marketable Securities $58.28M.
- 2026-03-31: Marketable Securities $61.77M.
- 2025-12-31: Marketable Securities $65.27M.
- 2025-09-30: Marketable Securities $70.66M.
| Period end | Marketable Securities | Marketable Securities as first filed |
|---|---|---|
| 2026-06-30 | $58.28M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $61.77M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $65.27M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $70.66M 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $69.74M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $104.61M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $84.72M 10-K · filed 2026-02-11 | |
| 2024-09-30 | $54.84M 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $52.47M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $58.34M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $59.50M 10-K · filed 2025-02-13 | |
| 2023-09-30 | $57.03M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $58.49M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $94.48M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $122.02M 10-K · filed 2024-02-14 | |
| 2022-09-30 | $117.84M 10-Q · filed 2022-10-31 | |
| 2022-06-30 | $145.05M 10-Q · filed 2022-08-01 | |
| 2022-03-31 | $67.27M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $71.82M 10-K · filed 2023-02-22 | |
| 2021-09-30 | $60.29M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $70.48M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $42.95M 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $52.29M 10-K · filed 2022-02-11 | |
| 2020-09-30 | $49.23M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $182.46M 10-Q · filed 2020-07-30 | |
| 2020-03-31 | $44.03M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $48.09M 10-K · filed 2021-02-12 | |
| 2019-09-30 | $135.75M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $40.26M 10-Q · filed 2019-08-02 | |
| 2019-03-31 | $38.45M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $38.36M 10-K · filed 2020-02-21 | |
| 2018-09-30 | $39.78M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $38.73M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $38.95M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $70.53M 10-K · filed 2019-02-22 | $81.21M 10-K · filed 2018-02-23 |
| 2017-09-30 | $257.49M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $326.13M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $421.63M 10-Q · filed 2017-05-02 | |
| 2016-12-31 | $336.98M 10-K · filed 2018-02-23 | $413.88M 10-K · filed 2017-02-24 |
| 2016-09-30 | $701.14M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $432.72M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $431.07M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $497.21M 10-K · filed 2017-02-24 | $440.37M 10-K · filed 2016-02-26 |
| 2015-09-30 | $952.99M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $971.83M 10-Q · filed 2015-08-05 | |
| 2014-12-31 | $364.10M 10-K · filed 2016-02-26 | |
| 2013-12-31 | $25.02M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |